The Role of Leukotriene Modifiers in the Treatment of Asthma
- 1 May 1998
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 157 (5), 1363-1371
- https://doi.org/10.1164/ajrccm.157.5.9706059
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trialJournal of Allergy and Clinical Immunology, 1996
- A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beingsJournal of Allergy and Clinical Immunology, 1996
- 271 The comparative effect of Zileuton, a 5-lipoxygenase inhibitori, plus low dose inhaled beclomethasone vs higher dose beclomethasone for asthmaJournal of Allergy and Clinical Immunology, 1996
- Leukotriene B4 induces interleukin 5 generation from human T lymphocytesEuropean Journal of Immunology, 1993
- Comparison of a β2-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected AsthmaNew England Journal of Medicine, 1991
- Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsThe Lancet, 1991
- Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients.Thorax, 1991
- Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D4–Receptor AntagonistNew England Journal of Medicine, 1990
- Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological EffectsScience, 1987
- Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.Thorax, 1984